Skip to main content
Jeena Sikho Lifecare Limited logo

Jeena Sikho Lifecare Limited — Investor Relations & Filings

Ticker · JSLL ISIN · INE0J5801029 LEI · 9845005B0A5066BDA982 BSE.NS Human health and social work activities
Open in API
Filings indexed 455 across all filing types
Latest filing 2026-05-30 Regulatory Filings
Country IN India
Listing BSE.NS JSLL

About Jeena Sikho Lifecare Limited

https://jeenasikho.com/

Jeena Sikho Lifecare Limited provides holistic wellness services and herbal products centered on traditional Ayurvedic principles. The company operates a network of specialized clinics and integrated hospitals under the Shuddhi Ayurveda and HIIMS brands. Its service model integrates Ayurveda, Naturopathy, and Homeopathy to manage chronic ailments and promote preventive health. Core activities include clinical consultations, the formulation and distribution of herbal supplements, and the implementation of lifestyle-based therapeutic programs. The company focuses on natural healing methodologies, offering a diverse portfolio of proprietary herbal medicines and dietary supplements designed to address various physiological conditions through non-invasive treatments.

Recent filings

Filing Released Lang Actions
1. Approval of Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2026. 2. Recommendation of Final Dividend of Rs. 4.50/- per ....
Regulatory Filings Classification · 82% confidence The document is a compliance filing under SEBI LODR Regulations 30 & 33 detailing the outcome of a Board meeting: approval of audited financial results (with attached auditor’s report), dividend recommendation, and internal auditor re-appointment. It is not a full annual report (10-K) or an interim/quarterly report in the US sense, nor is it a simple dividend notice or call transcript. This type of board outcome/financial-results announcement is a general regulatory disclosure, fitting the fallback category for miscellaneous exchange filings (Regulatory Filings – RNS).
2026-05-30 English
Annual Secretarial Compliance Report for the financial year ended 31st March 2026
Regulatory Filings Classification · 87% confidence The document is an Annual Secretarial Compliance Report issued by the Company Secretary under SEBI Listing Regulations (Regulation 24A). It is a compliance certification letter addressed to stock exchanges confirming statutory adherence for the year ended March 31, 2026. It contains no substantive financial statements or management discussion but is an attestation/certification of compliance and filings. Under the Certification Rule, such officer certifications fall under Regulatory Filings (RNS).
2026-05-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 75% confidence The document is an official intimation to stock exchanges under SEBI Listing Regulations, notifying the scheduling of an earnings conference call for Q4 FY26. It does not contain the actual financial results (so not an Earnings Release ER), nor is it a transcript (CT) or investor presentation (IP). It serves as a regulatory announcement under disclosure requirements, so it falls under the general Regulatory Filings category (RNS).
2026-05-27 English
Intimation of Earnings Conference Call for Investors and Analysts for Q4 FY26
Regulatory Filings Classification · 73% confidence The document is a formal SEBI Regulation 30 disclosure to stock exchanges, notifying investors and analysts of an upcoming earnings conference call for Q4 FY26. It does not contain actual financial results, transcripts, or slides; rather it is a regulatory announcement of an event. This fits as a general regulatory filing under Listing Obligations, which maps to the Regulatory Filings (RNS) category.
2026-05-27 English
General Updates
Regulatory Filings Classification · 90% confidence The document is an intimation under Regulation 30 of SEBI (LODR) Regulations, 2015, notifying stock exchanges about the publication of case studies and reports in external journals. It is a regulatory compliance disclosure rather than an actual financial report or meeting material. It does not contain financial statements or management commentary but is a general announcement of regulatory interest. Therefore, it falls under the general regulatory announcements category.
2026-05-25 English
Publication of Case Studies and Case Reports.
Regulatory Filings Classification · 90% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, sent to stock exchanges. It merely announces that case studies and case reports authored by company professionals have been published in various journals. There is no substantive financial data, management change, capital action, or dividend information. It is a regulatory compliance disclosure rather than an actual report. Hence, it fits the “Regulatory Filings” (RNS) category as a general LODR announcement.
2026-05-25 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.